Group B Market. 5.3.2.1 GENUPRO (directly or through its Affiliates and/or Sublicensees) will, subject to any legal obligations ALZA or its Affiliates or Third Party MAHs may have as holder of ALZA Marketing Authorizations or ALZA Regulatory Submissions prior to [*] or contractual obligations ALZA or its Affiliates may have under any Ancillary Agreement or with respect to a Third Party’s rights to market, promote, distribute and commercialize Agreement Product under a Distribution Agreement and subject to ALZA’s obligations with respect to the Ongoing Clinical Trials as set forth in Section 5.8.1, assume full responsibility and control over all aspects of the distribution and commercialization of the Agreement Product as of [*] in each Group B Market country, and the development and manufacture of Agreement Product anywhere for such purposes in each Group B Market country, [*]
Group B Market. 2.3.2.1 LICENSEE will, subject to any legal obligations ALZA or its Affiliates may have as holder of Product Registrations or Product Registration Applications prior to the Regulatory Transfer Date, ALZA’s obligations with regard to the Priligy On-Going Clinical Trials or contractual obligations ALZA or its Affiliates may have to LICENSEE, LICENSOR, or any Affiliate of either of the foregoing, assume full responsibility and control over all aspects of the distribution and commercialization of the Product as of the Effective Date in each Group B Market Country, and the development and manufacture of Product anywhere for such purposes in each Group B Market Country, except for the manufacture of Product by ALZA or its Affiliates pursuant to the Manufacturing Agreement.
